Clinical Trial Update: NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NT0102 in children with ADHD has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• NT0102

Snippet

Sponsor: Neos Therapeutics, Inc | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | Status: COMPLETED | Results posted: 2018-01-17